Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-005001
Filing Date
2025-01-13
Accepted
2025-01-13 08:00:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d853723d424b5.htm 424B5 507593
2 GRAPHIC g853723g58f53.jpg GRAPHIC 24453
  Complete submission text file 0001193125-25-005001.txt   542612
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B5 | Act: 33 | File No.: 333-281937 | Film No.: 25524878
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)